Jaguar Health Files 8-K: Material Agreement, Equity Sales
Ticker: JAGX · Form: 8-K · Filed: May 22, 2025 · CIK: 1585608
Sentiment: neutral
Topics: material-agreement, equity-sale, regulation-fd
TL;DR
Jaguar Health signed a big deal and sold some stock.
AI Summary
On May 20, 2025, Jaguar Health, Inc. entered into a material definitive agreement. The company also reported on unregistered sales of equity securities and provided a Regulation FD disclosure. The filing includes financial statements and exhibits.
Why It Matters
This 8-K filing indicates significant corporate activity for Jaguar Health, including a new material agreement and equity transactions, which could impact its financial standing and stock performance.
Risk Assessment
Risk Level: medium — The filing details material agreements and unregistered equity sales, which can introduce financial and regulatory risks.
Key Players & Entities
- Jaguar Health, Inc. (company) — Registrant
- May 20, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-36714 (file_number) — SEC File Number
- 200 Pine Street , Suite 400 San Francisco , California 94104 (address) — Principal executive offices
- (415) 371-8300 (phone_number) — Registrant's telephone number
FAQ
What type of material definitive agreement did Jaguar Health, Inc. enter into?
The filing states that Jaguar Health, Inc. entered into a material definitive agreement, but the specific details of the agreement are not provided in this summary.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on May 20, 2025.
What is Jaguar Health, Inc.'s state of incorporation?
Jaguar Health, Inc. is incorporated in Delaware.
What is the SEC file number for Jaguar Health, Inc.?
The SEC file number for Jaguar Health, Inc. is 001-36714.
What is the address of Jaguar Health, Inc.'s principal executive offices?
The principal executive offices of Jaguar Health, Inc. are located at 200 Pine Street, Suite 400, San Francisco, California 94104.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 22, 2025 regarding Jaguar Health, Inc. (JAGX).